accountA study has suggested that an anticholesterol drug, TriLipix, does not protect against heart attacks or strokes better than a generic medicine, according to a report released on Tuesday. As a result, uses of the drug, made by Abbott Laboratories, may be...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Drug Study a Setback for Abbott
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account